Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Journal of Periodontology|August 3, 2007
Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic resultsClay Walker, Susan Puumala, Lorne M Golub, et al.Journal of Periodontology|February 16, 2010
Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitisRichard A Reinhardt, Julie A Stoner, Lorne M Golub, et al.Mediators of Inflammation|January 24, 2014
4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammationYing Gu, Hsi-Ming Lee, Nicole Napolitano, et al.Journal of Experimental Pharmacology|February 17, 2022
The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in RatsHeta Dinesh Bhatt, Steve A McClain, Hsi-Ming Lee, et al.Antimicrobial Agents and Chemotherapy|April 18, 2002
A chemically modified tetracycline (CMT-3) is a new antifungal agentYu Liu, Maria E Ryan, Hsi-Ming Lee, et al.Journal of the American Dental Association (1939)|March 2, 2011
The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trialJeffrey B Payne, Lorne M Golub, Julie A Stoner, et al.Journal of Inflammation Research|October 27, 2021
A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental PeriodontitisJie Deng, Lorne M Golub, Hsi-Ming Lee, et al.American Journal of Respiratory and Critical Care Medicine|December 26, 2003
Alveolar instability causes early ventilator-induced lung injury independent of neutrophilsJay M Steinberg, Henry J Schiller, Jeffrey M Halter, et al.The Journal of Extra-Corporeal Technology|December 15, 2005
Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypassJeffrey Halter, Jay Steinberg, Gregory Fink, et al.Journal of Inflammation Research|March 2, 2023
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone LossHeta Dinesh Bhatt, Lorne M Golub, Hsi-Ming Lee, et al.Pageof 6